Marshall Wace
ESPR icon

Marshall Wace’s Esperion Therapeutics ESPR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.21M Buy
5,312,252
+1,679,294
+46% +$1.65M 0.01% 1028
2025
Q1
$5.23M Buy
+3,632,958
New +$5.23M 0.01% 969
2024
Q4
Sell
-3,092,629
Closed -$5.1M 2502
2024
Q3
$5.1M Sell
3,092,629
-1,210,967
-28% -$2M 0.01% 915
2024
Q2
$9.55M Buy
4,303,596
+2,087,635
+94% +$4.63M 0.01% 678
2024
Q1
$5.94M Buy
2,215,961
+1,758,203
+384% +$4.71M 0.01% 825
2023
Q4
$1.37M Sell
457,758
-1,116,378
-71% -$3.34M ﹤0.01% 1128
2023
Q3
$1.54M Buy
1,574,136
+1,258,207
+398% +$1.23M ﹤0.01% 1142
2023
Q2
$439K Buy
315,929
+28,324
+10% +$39.4K ﹤0.01% 1623
2023
Q1
$457K Buy
287,605
+112,582
+64% +$179K ﹤0.01% 1684
2022
Q4
$1.09M Sell
175,023
-385,964
-69% -$2.4M ﹤0.01% 1571
2022
Q3
$3.76M Buy
560,987
+534,387
+2,009% +$3.58M 0.01% 1303
2022
Q2
$169K Buy
+26,600
New +$169K ﹤0.01% 2492
2021
Q4
Sell
-520,095
Closed -$6.27M 3259
2021
Q3
$6.27M Sell
520,095
-651,975
-56% -$7.86M 0.03% 724
2021
Q2
$24.8M Buy
1,172,070
+142,369
+14% +$3.01M 0.11% 168
2021
Q1
$28.9M Sell
1,029,701
-346,229
-25% -$9.71M 0.13% 139
2020
Q4
$35.8M Buy
1,375,930
+9,825
+0.7% +$255K 0.19% 93
2020
Q3
$50.8M Buy
1,366,105
+75,331
+6% +$2.8M 0.33% 49
2020
Q2
$66.2M Sell
1,290,774
-33,173
-3% -$1.7M 0.46% 36
2020
Q1
$41.7M Buy
+1,323,947
New +$41.7M 0.42% 47
2019
Q2
Sell
-4,635
Closed -$186K 1443
2019
Q1
$186K Buy
+4,635
New +$186K ﹤0.01% 1332
2015
Q3
Sell
-12,182
Closed -$996K 960
2015
Q2
$996K Sell
12,182
-103,956
-90% -$8.5M 0.01% 602
2015
Q1
$10.8M Buy
116,138
+110,425
+1,933% +$10.2M 0.14% 188
2014
Q4
$231K Buy
+5,713
New +$231K ﹤0.01% 736